News

MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project

Date
April 6, 2022
No items found.

We are thrilled to announce that MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project.

Eurostars 3 program was established with the aim to support the most innovative European research and development enterprises.

The project aims at developing state-of-the-art diagnostic tests based on genomic data and artificial intelligence that will be used in the treatment of ovarian cancer patients. It will be carried out in collaboration with Macrogen Europe –  a Dutch company focused on DNA sequencing and bioinformatics services.

We hope that our solution will become the breakthrough thousands of cancer patients need in their treatment.

MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project
June 9, 2022

You may also like

Europe Biobank Week 2021

Almost a week has passed since the Europe Biobank Week 2021, and yet we are still impressed! We have attended great lectures, in which the speakers approached the topic of biobanking from different perspectives.

Greetings from ECML PKDD 2022!

Maciej Piernik presented one of our core algorithms at the European Conference on Machine Learning and Principles and Practice of Knowledge Discovery in Databases.

Krzysztof Bokiej is a speaker at Data Science Summit ML Edition

Krzysztof Bokiej - Head of Platform and Pipelines at MNM - is a speaker at the most important Machine Learning conference in Poland.

MNM Bioscience eyes cancer drug target discovery based on its AI algorithms

MNM Bioscience began as a bioinformatics company that curates data and then builds artificial intelligence-based algorithms, but it is now looking to branch out into oncology drug target discovery.